European Union & Coalition for Epidemic Preparedness Innovations

European Union: The EU is the regulatory jurisdiction where the approval applies; this expands vaccine access for children across member states, supporting public health.

Coalition for Epidemic Preparedness Innovations: CEPI co-funded the Phase 2 study supporting the approval; this aligns with its mission to accelerate vaccine development, though it has no direct financial stake.

European Union: The European Union has provided critical medical supplies, including masks, gloves, boots, and medications, to aid the Ebola response in the Democratic Republic of the Congo.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) is funding three groups, including Moderna and the University of Oxford, to accelerate the development of vaccines against the Bundibugyo strain of Ebola.

European Union: A spokesperson for the European Union>>> stated that the risk of an Ebola outbreak in Europe is 'very low', indicating monitoring of the situation but no immediate alarm for the region.

Coalition for Epidemic Preparedness Innovations: The Coalition for Epidemic Preparedness Innovations (CEPI) funds vaccine development and is assessing potential Ebola vaccine candidates, aiming for a rapid response.

European Union: The European Union considers the risk to its general public very low but has begun coordinating laboratory preparedness and traveler guidance through its Health Security Committee.

Coalition for Epidemic Preparedness Innovations: CEPI is listed as a partner in the urgent coordination meeting convened by Africa CDC, indicating potential involvement in the response to the Ebola outbreak.

European Union: EU funding contributed to the research, aligning with its health security goals.

Coalition for Epidemic Preparedness Innovations: CEPI is mentioned as an organization Woolhouse has advised, but no direct involvement in the catalogue.